A Novel Protein Geranylgeranyltransferase-I Inhibitor with High Potency, Selectivity, and Cellular Activity
Open Access
- 1 May 2006
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 281 (18) , 12445-12450
- https://doi.org/10.1074/jbc.m600168200
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Anti-RhoA and Anti-RhoC siRNAs Inhibit the Proliferation and Invasiveness of MDA-MB-231 Breast Cancer Cells in Vitro and in VivoMolecular Therapy, 2005
- Crystallographic Analysis of CaaX Prenyltransferases Complexed with Substrates Defines Rules of Protein Substrate SelectivityJournal of Molecular Biology, 2004
- Prenylation inhibitors: a novel class of antiviral agentsJournal of Antimicrobial Chemotherapy, 2003
- High Affinity for Farnesyltransferase and Alternative Prenylation Contribute Individually to K-Ras4B Resistance to Farnesyltransferase InhibitorsJournal of Biological Chemistry, 2003
- Synergistic cytotoxic effects in myeloid leukemia cells upon cotreatment with farnesyltransferase and geranylgeranyl transferase-I inhibitorsLeukemia, 2003
- Lovastatin inhibits brain endothelial cell Rho‐mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitisThe FASEB Journal, 2003
- Gα12 and Gα13 Negatively Regulate the Adhesive Functions of CadherinJournal of Biological Chemistry, 2002
- Inhibition of Protein Geranylgeranylation and RhoA/RhoA Kinase Pathway Induces Apoptosis in Human Endothelial CellsJournal of Biological Chemistry, 2002
- RHO–GTPases and cancerNature Reviews Cancer, 2002
- Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messengers.The Journal of cell biology, 1992